XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible Assets, net
3 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets, net

Note 8 — Intangible Assets, net

 

Intangible assets, less accumulated amortization, consisted of the following as of:

   

   Estimated Useful Life 

March 31,

2023

  

December 31,

2022

 
Defensive asset  60 months  $2,105   $2,105 
Laboratory licenses and certifications and laboratory information management software  24 months   3,200    3,200 
Other  1 year   70    70 
Total Intangible assets      5,375    5,375 
Less Accumulated Amortization      (2,435)   (1,930)
Intangible Assets, net     $2,940   $3,445 

 

The defensive technology intangible asset was recognized upon its acquisition of CapNostics, an unrelated third-party, for total purchase consideration paid on the October 5, 2021 acquisition date of approximately $2.1 million in cash. The CapNostics transaction was accounted for as an asset acquisition, resulting in the recognition of the defensive technology intangible asset. The defensive technology intangible asset is being amortized on a straight-line basis over an expected useful life 60 months commencing on the acquisition date.

 

The intangible assets recognized under the APA-RDx are the laboratory licenses and certifications, inclusive of a CLIA certification, CAP accreditation, and clinical laboratory licenses for five (5) U.S. States transfer to the Company from RDx, and a laboratory information management software perpetual-use royalty-free license granted under the APA-RDx, with such intangible asset having a useful life of twenty-four months commencing on the APA-RDx February 25, 2022 transaction date.

 

Amortization expense of the intangible assets discussed above was $505 and $123 for the periods ended March 31, 2023 and 2022, respectively, and is included in amortization of acquired intangible assets in the accompanying unaudited condensed consolidated statements of operations. As of March 31, 2023, the estimated future amortization expense associated with the Company’s finite-lived intangible assets for each of the five succeeding fiscal years is as follows:

 

      
2023 (remainder of year)  $1,516 
2024   688 
2025   421 
2026   315 
Total  $2,940